Skip to main content
BMJ Case Reports logoLink to BMJ Case Reports
. 2018 Aug 3;2018:bcr2018224539. doi: 10.1136/bcr-2018-224539

Plaque psoriasis following Kawasaki disease and varicella

Hedwig Sillen 1, Michaëla Maes 2, Tine Boiy 3, Marek Wojciechowski 3
PMCID: PMC6078230  PMID: 30077967

Abstract

We describe the case of a 15-month-old boy with Kawasaki disease who developed varicella 7 days after the beginning of the disease and diffuse plaque psoriasis after 43 days. Associations between Kawasaki disease and psoriasis, between Kawasaki disease and varicella and between varicella and psoriasis have all been reported in the literature. The triple association of Kawasaki disease, varicella and psoriasis is very rare. Neither the double nor the triple associations are well known among a diverse group of practitioners.

Keywords: paediatrics, infectious diseases, cardiovascular medicine, dermatology

Background

Kawasaki disease (KD) is an acute vasculitis of unknown aetiology that mainly affects children younger than 5 years of age. The diagnosis is based on clinical criteria: fever persisting for 5 days or more, and at least four of five principal clinical features: oral mucous membrane changes, polymorphous rash, bilateral bulbar conjunctival injection, peripheral extremity changes and cervical lymphadenopathy.1 The disease progresses in three stages: the acute febrile stage lasting about 10–12 days, the subacute stage lasting 2 weeks which is associated with the development of coronary aneurysms in 20%–25% of the untreated children and the convalescent stage lasting about 6 weeks until normalisation of the inflammatory parameters.

The aetiology of KD is not known. It is believed that an infectious agent induces an abnormal immune response in genetically predisposed individuals.2 Infection with varicella zoster virus (VZV) has been associated with KD in a few reports.3–9

The occurrence of psoriasis in the acute, subacute or convalescent phase of KD has been described in several reports.10–22 Imbalance between upregulated T-helper 17 (Th17) cells and downregulated regulatory T (Treg) cells, leading to increased expression of interleukin (IL)-17, plays a role in the pathogenesis of KD.23 Th17 cells and IL-17 are involved in the pathogenesis of psoriasis as well.24

Varicella has also been described as a possible inducer of psoriasis. Immunological mechanisms as well as the Koebner phenomenon appear to be involved.25 26

The triple association of KD, varicella and psoriasis is rare, we have not found any citation in PubMed.

Case presentation

A 15-month-old boy was admitted with high fever and vomiting since 3 days. The temperature was 39.1° C. At physical examination, he appeared ill without a clear focus for the fever. The abdomen was tender. Blood examination revealed 9.2×109/L white cell count (WBC), with 31% band forms, 29% segmented neutrophils and 29% lymphocytes; the haemoglobin concentration was 108 g/L, platelet count was 405×109/L; C reactive protein was 191 mg/L. Urine examination showed 459 WBC/µL (culture proved negative later, as well as haemoculture). A chest radiograph and abdominal ultrasonography were normal. Septicaemia was suspected and treatment with cefotaxime was started. Despite therapy the fever persisted and 2 days after hospitalisation (on the fifth day of fever) he developed red and dry fissured lips, hyperaemic oral mucosa, a strawberry tongue, skin rash, bilateral conjunctivitis, cervical lymphadenitis and oedematous hands and feet. KD was diagnosed. Treatment with intravenous immunoglobulins 2 g/kg and acetylsalicylic acid 80 mg/kg/day was initiated. The fever disappeared on the following day. Echocardiography revealed no coronary lesions and the dose of acetylsalicylic acid was reduced to 5 mg/kg/day. On the seventh day, he developed varicella. He was discharged on day 9.

Ten days later, on day 19, he developed fever up to 39°C again. At physical examination, he had crackled lips and peeling of the skin on fingertips and toes. All varicella lesions were dry. Blood examination revealed 15.6×109/L WBC with a normal differential and 600×109/L platelets; the C reactive protein was 96,1 mg/L. Urine examination demonstrated 52 WBC/µL. A second dose of intravenous immunoglobulins was administered. Echocardiography remained normal and the fever disappeared after 1 day. He was discharged, but 1 day later, Staphylococcus aureus was cultured from the urine. Since he was generally well and demonstrated no signs of urinary tract infection, treatment with antibiotics was not initiated and the organism was considered as a contaminant.

Three weeks later, on day 43, clinical examination during follow-up visit revealed multiple nummular, erythematous and desquamating skin lesions at the site of healed varicella lesions. Plaques were seen on the trunk and the proximal extremities. Perioral lesions with hyperaemic mucosa and crackles around the lips were present as well. The dermatologist classified these lesions as diffuse plaque psoriasis (figure 1). Treatment with topical mometasone furoate 1 mg/g supported resolution of the lesions within 3 weeks.

Figure 1.

Figure 1

Diffuse plaque psoriasis lesions.

Outcome and follow-up

There was no recurrence of lesions at follow-up 1 year later. Familial history revealed that the paternal grandmother suffered from psoriasis.

Discussion

Autoimmune phenomena can be triggered by environmental factors in genetically susceptible individuals. Among environmental factors Infections are an important trigger.27 Therefore, coincidental or sequential presentation of infections and autoimmune problems is not rare.

Many bacterial and viral agents have been associated with KD, although their role is not entirely clarified.1 Among these agents, VZV has been associated with KD. Varicella preceding KD was reported in four articles and during the acute stage in three articles.3–9 Thus, infection with VZV might be a trigger for KD. VZV replicates in the body during its incubation period (11–20 days) and viraemia can be detected as early as 10 days before the occurrence of rash.28 29 Our patient developed varicella skin lesions during the acute phase of KD, 7 days after the onset of fever. Thus, we assume that VZV triggered KD in our patient.

The association of KD with psoriasis has been reported in at least 32 children.10–22 A synopsis of these cases is shown in table 1. Psoriasis associated with KD is mostly plaque psoriasis and resolves without recurrences.

Table 1.

Cases of Kawasaki-induced psoriasis described in the English literature

Author, year Numbers of patients KD phase during which psoriasis arose Type of psoriasis Localisation Time for the psoriatic lesions to disappear Familial predisposition for psoriasis
Han et al,10 2000 1 Subacute phase Guttate psoriasis Face, trunk, extremities Gradually disappearing Not described
Eberhard et al,11 2000 10 Subacute phase:five patients
Convalescent phase:five patients
Pustular Psoriasis: three patients
Plaque psoriasis: seven patients
Trunk, extremities
Trunk, knees, elbows
Rapidly resolving with no recurrence Two patients
Garty et al,12 2001 1 Subacute phase Guttate psoriasis Trunk, extremities 1 year after disappearance of KD Not described
Boralevi et al,13 2003 1 Convalescent Pustular and guttate psoriasis Trunk, extremities 2 months Not described
Zvulunov et al,14 2003 1 Acute phase
Convalescent phase
Pustular psoriasis
Plaque psoriasis
Sole of a foot
Cheeks, extensor side extremities
Gradual, spontaneous disappearing Not described
Menni et al,15 2006 1 Acute phase Plaque psoriasis Trunk 2 months Not described
Mizuno et al,16 2006 1 Convalescent phase Plaque psoriasis (psoriasis vulgaris)
Pustular lesions
Cheeks, extensor region left upper arm (BCG vaccine)
Palms and soles
Gradual disappearing Not described
Yoon et al,17 2007 1 Subacute phase Plaque psoriasis Extremities, trunk 1 month Not described
Liao and Lee,18 2009 1 Acute phase Psoriasiform papules and plaques Face, extremities 1 month Not described
Ergin et al,19 2009 1 Subacute phase Plaque psoriasis Cheeks, trunk, extremities 3 weeks Mother
Kishimoto et al,20 2010 1 Acute phase – after intake of infliximab Psoriasiform papules and plaques Extensor surface extremities Few weeks Not described
Haddock et al,21 2016 11 Acute phase: two patients
Subacute phase: three patients
Convalescent phase: six patients
Plaque psoriasis: nine patients
Guttate psoriasis: one patient
Psoriatic nail pitting: one patient
Diaper area, trunk, extensor extremities, face 1.6 to 17.9 months One patient
Geller and Kellen,22 2017 1 Subacute phase Plaque psoriasis Face, arms, legs 3 weeks, no recurrence Not described

KD, Kawasaki disease.

Psoriasis developing after varicella infection has also been reported in the literature.25 26 30–32 Plaque or guttate psoriasis lesions appear after 2 weeks to 3 months on skin areas that were affected by varicella. This is probably related to the Koebner phenomenon (the appearance of psoriatic lesions on the skin of psoriatic patients as a consequence of local trauma). Family history of psoriasis in an affected patient and resolution without recurrence has been described in one article.30

Proinflammatory cytokines, among others interferon γ, tumour necrosis factor alpha and IL-6, are produced during the acute phase of KD or varicella.14 33 Activation of myeloid dendritic cells by these cytokines leads to activation of Th17 cells and expression of IL-17/IL-22. IL-17 appears to play an important role in KD, but is also known to be involved in the pathogenesis of psoriasis by activating keratinocytes to produce psoriasis associated molecules. On resolution of KD, the amount of cytokines in the inflammatory environment diminishes, downregulating the T-cell response and therefore leading to resolution of the psoriatic skin lesions.11 15 Hence, similarities in immunological pathways may induce the development of psoriatic lesions in persons with a psoriatic constitution.24 34 35 This is an example of how immunological processes can lead to coincidental associations of infection and autoimmune pathology in genetically predisposed persons.

Our patient developed plaque psoriasis at the site of healed varicella lesions suggesting a Koebner phenomenon induced by local skin damage caused by the chickenpox. As the family history revealed psoriasis in his paternal grandmother, we hypothesise the presence of a genetic predisposition promoting induction of psoriatic lesions by KD or varicella or both. It is reported that psoriatic lesions after KD tend to disappear gradually. In our patient, the lesions disappeared after 3 weeks, without recurrence at follow-up after 1 year. It is not clear if the development of psoriatic lesions after KD and varicella entails the development of psoriasis later in life.

As varicella has been associated with Reye syndrome, the use and dosage of acetylsalicylic acid in our case can be a matter of discussion. Our patient presented in 2013 and at that time high doses of acetylsalicylic acid were commonly used in the acute phase of KD. When treatment was initiated, no varicella lesions were present. When they appeared, the dosage was already reduced to low dose. Although a low dose for antiplatelet effect has not been associated with Reye syndrome, acetylsalicylic acid could have been replaced by another antiplatelet agent such as thienopyridine.1

Conclusion

Triggering of autoimmune phenomena by infection and similarities in immunopathogenesis can explain the triple association of varicella, KD and psoriasis in our patient. This triple association is rare. Double associations between KD and psoriasis, varicella and psoriasis, and KD and varicella have been described but are not well known. We consider this case report as an opportunity to highlight these aspects of KD.

Learning points.

  • Associations between Kawasaki disease (KD) and psoriasis, varicella and psoriasis, and KD and varicella have been reported in the literature, but the triple association varicella, KD and psoriasis is rare.

  • Triggering of autoimmune phenomena by infection in genetically predisposed individuals and similarities in their immunopathogenesis can explain coincidental or sequential associations between these pathologies.

  • Psoriatic lesions after KD disappear gradually. Whether the development of psoriatic lesions after KD and varicella entails the development of psoriasis later in life in not known.

Footnotes

Contributors: HS and MW: conceived, drafted the manuscript and wrote the final version. MM and TB: have revised and corrected the draft and approved the final version. All authors have participated in the analysis and interpretation of data.

Funding: The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

Competing interests: None declared.

Patient consent: Parental/guardian consent obtained.

Provenance and peer review: Not commissioned; externally peer reviewed.

References

  • 1.McCrindle BW, Rowley AH, Newburger JW, et al. Diagnosis, treatment, and long-term management of kawasaki disease: A scientific statement for health professionals from the american heart association. Circulation 2017;135:e927–99. 10.1161/CIR.0000000000000484 [DOI] [PubMed] [Google Scholar]
  • 2.Dietz SM, van Stijn D, Burgner D, et al. Dissecting Kawasaki disease: a state-of-the-art review. Eur J Pediatr 2017;176:995–1009. 10.1007/s00431-017-2937-5 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Kuijpers TW, Tjia KL, de Jager F, et al. A boy with chickenpox whose fingers peeled. Lancet 1998;351:1782 10.1016/S0140-6736(98)04021-5 [DOI] [PubMed] [Google Scholar]
  • 4.Ogboli MI, Parslew R, Verbov J, et al. Kawasaki disease associated with varicella: a rare association. Br J Dermatol 1999;141:1136–52. 10.1046/j.1365-2133.1999.03231.x [DOI] [PubMed] [Google Scholar]
  • 5.Plesiat-Trommsdorff V, Combes JC. [Varicella and Kawasaki syndrome: cause or association?]. Arch Pediatr 2003;10:358–9. [DOI] [PubMed] [Google Scholar]
  • 6.Duzova A, Topaloglu R, Keskin M, et al. An unusual pattern of arthritis in a child with Kawasaki syndrome. Clin Rheumatol 2004;23:73–5. 10.1007/s10067-003-0828-9 [DOI] [PubMed] [Google Scholar]
  • 7.Lee DH, Huang HP. Kawasaki disease associated with chickenpox: report of two sibling cases. Acta Paediatr Taiwan 2004;45:94–6. [PubMed] [Google Scholar]
  • 8.Turkay S, Odemis E, Karadag A. Kawasaki disease onset during concomitant infections with varicella zoster and Epstein-Barr virus. J Natl Med Assoc 2006;98:1350–2. [PMC free article] [PubMed] [Google Scholar]
  • 9.Toprak D, Serçe Ö, Türel Ö, et al. Is varicella zoster virus an etiologic factor in kawasaki disease? a case report and review of the literature. Glob Pediatr Health 2015;2:2333794X1456719 10.1177/2333794X14567194 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Han MH, Jang KA, Sung KJ, et al. A case of guttate psoriasis following Kawasaki disease. Br J Dermatol 2000;142:548–50. 10.1046/j.1365-2133.2000.03376.x [DOI] [PubMed] [Google Scholar]
  • 11.Eberhard BA, Sundel RP, Newburger JW, et al. Psoriatic eruption in Kawasaki disease. J Pediatr 2000;137:578–80. 10.1067/mpd.2000.107840 [DOI] [PubMed] [Google Scholar]
  • 12.Garty B, Mosseri R, Finkelstein Y. Guttate psoriasis following Kawasaki disease. Pediatr Dermatol 2001;18:507–8. 10.1046/j.1525-1470.2001.1862002.x [DOI] [PubMed] [Google Scholar]
  • 13.Boralevi F, Barat P, Lepreux S, et al. [Kawasaki’s disease with eruptive pustular and guttate psoriasis]. Ann Dermatol Venereol 2003;130:528–31. [PubMed] [Google Scholar]
  • 14.Zvulunov A, Greenberg D, Cagnano E, et al. Development of psoriatic lesions during acute and convalescent phases of Kawasaki disease. J Paediatr Child Health 2003;39:229–31. 10.1046/j.1440-1754.2003.00117.x [DOI] [PubMed] [Google Scholar]
  • 15.Menni S, Gualandri L, Boccardi D, et al. Association of psoriasis-like eruption and Kawasaki disease. J Dermatol 2006;33:571–3. 10.1111/j.1346-8138.2006.00134.x [DOI] [PubMed] [Google Scholar]
  • 16.Mizuno Y, Suga Y, Muramatsu S, et al. Psoriasiform and palmoplanter pustular lesions induced after Kawasaki disease. Int J Dermatol 2006;45:1080–2. 10.1111/j.1365-4632.2005.02524.x [DOI] [PubMed] [Google Scholar]
  • 17.Yoon SY, Oh ST, Lee JY, et al. A plaque type psoriasiform eruption following Kawasaki disease. Pediatr Dermatol 2007;24:96–8. 10.1111/j.1525-1470.2007.00349.x [DOI] [PubMed] [Google Scholar]
  • 18.Liao YC, Lee JY. Psoriasis in a 3-month-old infant with Kawasaki disease. Dermatol Online J 2009;15:10. [PubMed] [Google Scholar]
  • 19.Ergin S, Karaduman A, Demirkaya E, et al. Plaque psoriasis induced after Kawasaki disease. Turk J Pediatr 2009;51:375–7. [PubMed] [Google Scholar]
  • 20.Kishimoto S, Muneuchi J, Takahashi Y, et al. Psoriasiform skin lesion and supprative acrodermatitis associated with Kawasaki disease followed by the treatment with infliximab: a case report. Acta Paediatr 2010;99:1102–4. 10.1111/j.1651-2227.2010.01745.x [DOI] [PubMed] [Google Scholar]
  • 21.Haddock ES, Calame A, Shimizu C, et al. Psoriasiform eruptions during Kawasaki disease (KD): A distinct phenotype. J Am Acad Dermatol 2016;75:69–76. 10.1016/j.jaad.2016.02.1146 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Geller L, Kellen R. Tumor necrosis factor antagonist-induced psoriasis in a 3-year-old boy with Kawasaki disease. Dermatol Online J 2017;23. [PubMed] [Google Scholar]
  • 23.Jia S, Li C, Wang G, et al. The T helper type 17/regulatory T cell imbalance in patients with acute Kawasaki disease. Clin Exp Immunol 2010;162:131–7. 10.1111/j.1365-2249.2010.04236.x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Marinoni B, Ceribelli A, Massarotti MS, et al. The Th17 axis in psoriatic disease: pathogenetic and therapeutic implications. Auto Immun Highlights 2014;5:9–19. 10.1007/s13317-013-0057-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Singh S, Singh S, Singh U. Induction of psoriasis and Koebner’s phenomenon. J Dermatol 2010;37:568–9. 10.1111/j.1346-8138.2009.00767.x [DOI] [PubMed] [Google Scholar]
  • 26.Ito T, Furukawa F. Psoriasis guttate acuta triggered by varicella zoster virus infection. Eur J Dermatol 2000;10:226–7. [PubMed] [Google Scholar]
  • 27.Galli L, Chiappini E, de Martino M. Infections and autoimmunity. Pediatr Infect Dis J 2012;31:1295–7. 10.1097/INF.0b013e3182757c4d [DOI] [PubMed] [Google Scholar]
  • 28.Richardson M, Elliman D, Maguire H, et al. Evidence base of incubation periods, periods of infectiousness and exclusion policies for the control of communicable diseases in schools and preschools. Pediatr Infect Dis J 2001;20:380–91. 10.1097/00006454-200104000-00004 [DOI] [PubMed] [Google Scholar]
  • 29.Gershon AA, Breuer J, Cohen JI, et al. Varicella zoster virus infection. Nat Rev Dis Primers 2015;1:15016 10.1038/nrdp.2015.16 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Kokolakis GP, Ioannidou D, Cholongitas E, et al. Guttate psoriasis occurring on varicella lesions. J Dermatol 2010;37:857–9. 10.1111/j.1346-8138.2010.00886.x [DOI] [PubMed] [Google Scholar]
  • 31.Hendrie J. Psoriasis, the köbner phenomenon and varicella - a case report. Can Fam Physician 1975;21:84–5. [PMC free article] [PubMed] [Google Scholar]
  • 32.Müller H, Fäh J, Dummer R. [Unusual Koebner phenomenon in psoriasis caused by varicella and UVB]. Hautarzt 1997;48:130–2. [DOI] [PubMed] [Google Scholar]
  • 33.Wang JP, Kurt-Jones EA, Shin OS, et al. Varicella-zoster virus activates inflammatory cytokines in human monocytes and macrophages via Toll-like receptor 2. J Virol 2005;79:12658–66. 10.1128/JVI.79.20.12658-12666.2005 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Takahashi K, Oharaseki T, Yokouchi Y. Update on etio and immunopathogenesis of Kawasaki disease. Curr Opin Rheumatol 2014;26:31–6. 10.1097/BOR.0000000000000010 [DOI] [PubMed] [Google Scholar]
  • 35.Speeckaert R, Lambert J, Grine L, et al. The many faces of interleukin-17 in inflammatory skin diseases. Br J Dermatol 2016;175:892–901. 10.1111/bjd.14703 [DOI] [PubMed] [Google Scholar]

Articles from BMJ Case Reports are provided here courtesy of BMJ Publishing Group

RESOURCES